President Trump is expected to give a speech Tuesday about his plan to lower drug prices, and it has the industry on edge; despite the president telling crowds that the Affordable Care Act (ACA) is deceased, many pieces of it are alive and angering business groups; Idaho officials are still hoping to allow insurers to sell plans that don't comply with the ACA and are negotiating with federal officials over risk pools, risk adjustment programs, essential health benefits, and other issues.
President Trump is expected to give a speech Tuesday about his plan to lower drug prices, and it has the industry on edge, The Hill reported. Observers are wondering what will actually get said, since the president is known to ad lib; the speech could also be pushed back to later in the week. Other things to watch are if Trump will follow former President Obama on Medicare Part B drug pricing, if he will follow through on a campaign promise to allow Medicare to negotiate prices directly, and what will he say about pharmaceutical imports.Despite President Trump telling crowds that the Affordable Care Act (ACA) is deceased, many pieces of it are alive and angering business groups, The New York Times reported. And the Trump administration is even enforcing some of its provisions more aggressively than the previous administration, namely the employer mandate—the requirement that most companies offer health insurance to their workers or pay a penalty. The IRS has been sending penalty notices to more than 30,000 businesses around the country, the paper reported.Idaho officials are still hoping to allow insurers to sell plans that don't comply with the Affordable Care Act (ACA) and are negotiating with federal officials over risk pools, risk adjustment programs, essential health benefits, and other issues. The state says the action is needed to save Idaho's insurance exchange as premiums continue to rise and some healthy residents opt to go uninsured, the Associated Press reported.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More